Kala Bio Inc Expected To Post A Loss Of $2.28 A Share: Earnings Preview
25/03/2025 12:41
KALA BIO Inc KALA.OQ KALA.O is expected to show no change in quarterly revenue when it reports results on March 27 (estimated) for the period ending December 31 2024 LSEG's mean analyst estimate for KALA BIO Inc is for a loss of $2.28 per share. The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for KALA BIO Inc is $15.00, above its last closing price of $6.86. This summary was machine generated March 25 at 12:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)